A new styryl lactone, 5R,6R-5-hydroxy-6-styryltetrahydropyrane-2-one 2 was isolated from the roots of an endemic Goniothalamus lanceolatus Miq. of Sarawak, Malaysia. Furthermore, seven previously undescribed diastereomers, 5R,6R-5-hydroxygoniothalamin 3, 5R,6R-5-acetylgoniothalamin 4, 6S,7S,8S-goniodiol-7-monoacetate 5, 6S,7S,8S-goniodiol-8-monoacetate 6, goniofupyrone B 7, deoxygoniopypyrone B 8 and 1S,5S,7R,8S,3-endo,7-endo-(+)-8-epi-9-deoxygoniopypyrone acetate 9, along with six known styryl lactones (1, 10-15) were also isolated and characterized. 6S-goniothalamin 1 is reported for the first time from a Goniothalamus species. 1, 11 and 12 showed cytotoxic activity against human colon and lung cancer cell lines with IC 50 values ranging from 2.38-7.59 µM.
Goniothalamus lanceolatus
Miq. is an ethnomedicinal plant indigenous to Sarawak, Malaysia, used as traditional remedy for fever, skin infection, postpartum, abortion, as well as cancer treatment [1] . We previously reported cytotoxic lactam alkaloid and naphthoquinones from the roots of this plant [2] . Generally, Goniothalamus species are dominated by presences of styryl lactones. In continuation of our study on G. lanceolatus Miq., we herein report series of interesting styryl lactone derivatives from the roots and barks of the plant. The cytotoxic activity of the styryl lactones against a panel of human lung and colon cancer cell lines are also reported.
6S-goniothalamin 1 α -57.1, negative Cotton effect (CE) at 254 nm in ECD spectrum, isolated from roots of G. lanceolatus Miq., is reported for the first time from a Goniothalamus species [3, 4] . This particular configuration at C-6 of 1 forms the basis of establishing configuration of C-6 in all other styryl pyrones, and C-1 in the case of furano-pyrone and pyrano-pyrone isolated from this plant.
Compound 2 was obtained as a brown oil, α -11.1 (c 0.20, MeOH) with molecular formula C 13 H 14 O 3 Na, determined by pseudomolecular ion peak LC-ESI-OBITRAP-MS at m/z 241.0833 (calculated 241.0835) [ carbonyl (δ C 177.1; C-2), aromatic ring (δ C 126.9, 128.5, 128.9 and 136.1; C-10, C-12, C-11 and C-9), olefinic (δ C 125.9 and 134.2; C-7 and C-8), methylene (δ C 24.0 and 28.7; C-4 and C-3) and oxymethine (δ C 75.2 and 82.7; C-6 and C-5) carbons, in which signals at δ C 126.9 and 128.9 are presenting two carbons each. Long range correlation was observed between H-3 to C-2, C-4 and C-5, and H-4 to C-2, C-3, C-5 and C-6 which led to establishment of pyrano lactone moiety in chair conformation. 2) H-11, H-13 C-11,C-12, C-13 a J-values are given in Hz correlation of olefinic protons H-7 and H-8 to C-6 and C-9, indicated that they are located at the bridge between lactone and benzene rings.
From biogenesis point of view the configuration at C-6 of 2 will be the same as 6S-goniothalamin 1, with the H-6 in the axial orientation. However, the C-6 configuration of 2 is assigned as Rdue to change of priority sequence as the result of hydroxyl substituent on C-5. The coupling constant between H-5 and H-6 is 5.4 Hz, indicating that the dihedral angle is close to 45º, thus establishing H-5 is in equatorial orientation, leading to Rconfiguration. Based on the presented spectral data ( Table 1) , structure of 2 is concluded as a new compound 5R,6R-5-hydroxy-6-styryltetrahydropyrane-2-one, depicted in Figure 1 .
Compound 3 is similar to 2 with the only difference is the presence of a double bond between C-3 and C-4 as indicated by the 13 C-NMR at δ C 125.1 and 140.9. The configuration of 3 was established by coupling constant analysis, specific rotation value and ECD profile. As in 2, C-6 and C-5 of 3 have R-configurations. The negative CE was observed in the region 230-250 with specific rotation of -63.2, which are opposite to that of 6S-5-hydroxygoniothalamin [5] . Hence, 3 was established as 5R,6R-5-hydroxygoniothalamin, a new diastereomer of 5-hydroxygoniothalamin. Compound 4 is an acetyl derivative of 3, 5R-6R-5-acetylgoniothalamin, also a previously undescribed diastereomer. The EDC spectra of 1, 3 and 4 are illustrated in Figure 2 . (6S,7S,8S)-goniodiol-7-monoacetate 5 and (6S,7S,8S)-goniodiol-8-monoacetate 6 were obtained from the barks of G. lanceolatus Miq. A furano-pyrone, goniofupyrone B 7 and two pyrano-pyrone, deoxygoniopypyrone B 8 and 1S,5S,7R,8S,3-endo,7-endo-(+)-8-epi-9-deoxygoniopypyrone acetate 9, possessing 1S-configuration are also previously undescribed diastereomers. Compounds 10-15 were identified as (6S,7S,8S)-goniodiol 10 [3, 6], (6S,7S,8R)-8-chlorogoniodiol 11 [3] , (-)-ent-goniothalamin oxide 12 [3, 7] , Parvistone D 13 [3, 6] , 1S,5S,7R,8S,3-exo,7-endo-(+)-8-epi-9-deoxygoniopypyrone 14 [3, 8] and parvistone E 15 [3] .
The isolated compounds were evaluated for their cytotoxicity against a panel of human colon (SW48 and HCT116) and lung (A549, NCI-H23 and NCI-H1299) cancer cell lines. Compound 1, 3, 4, 10, 11, 12 and 13 showed percent viability of less than 50% tested at a concentration of 10 µM, thus IC 50 were determined and summarized in Table 2 . Among these compounds, 1, 11 and 12 exhibited cytotoxic activity with IC 50 values ranging 2.38-7.59 µM, less than the positive control, 5-fluorouracil (IC 50 12.33-24.12 µM). 5-Fluorouracil is a conventional chemotherapy agent which shows cytotoxicity effects against both non-cancerous and cancerous cell [9] . Compound 11 demonstrated stronger cytotoxicity against NCI-H23 and SW48 at IC 50 2.38 and 2.45 µM, respectively, whilst, 1 exhibited cytotoxicity towards on HCT116 with IC 50 of 2.66 µM. Meanwhile, 3, 4, 10 and 13 showed IC 50 values higher than positive control against all cancer cell lines. Interestingly, all isolated compounds were non-toxic against non-cancerous cell lines (CCD 841 CoN and MRC-5). Experimental General: Specific rotations were recorded on MCP 200 Modular Circular Polarimeter in MeOH at 20°C and infrared (IR) spectra were recorded on a Perkin-Elmer apparatus using the KBR pellet method. The 1D-and 2D-NMR spectra were recorded in chloroform-d using a Bruker 600 Ascend™ NMR spectrometer and the mass spectrum was collected by Thermo Fisher Scientific Accela™ UHPLC system coupled with LTQ Obitrap Discovery Hybrid Ion Trap-Orbitrap Mass Spectrometer. Data acquisition and processing were performed using Thermo Xcalibur Qualitative software. Mass spectra using the LC-ESI-OBITRAP-MS were recorded in the range of m/z 100-1000 in the positive ion mode with Dual Electrospray Ionisation (ESI) operated at a sheath gas flow rate 40 arb and auxiliary gas flow rate 20 arb (capillary temperature 350°C). Medium pressure liquid chromatography (MPLC) was performed using silica gel by YFLC W-Prep 2×Y (Type B-1) system. Semi-Preparative HPLC Agilent 1200, Preparative HPLC of Gilson PLC 2020 and Recycling HPLC of LC-9130 Next were used for the isolation and purification steps. The CD spectra were obtained from Jasco J-810 Circular Dichroism Spectropolarimeter. to 100% of B in 3 min and 100% of B in 7 min at a constant flow rate 13.7 mL/min to give 1 (9.7 mg) and 4 (1.9 mg). Fraction R4 (3.2 g) was also fractionated using the same conditions of R3 by gradient elution; 30 to 75% of B in 35 min, followed by 75 to 100% of B in 3 min, and 100% of B in 12 min to give 2 (5.3 mg), 3 (33.5mg) and 13 (364.1 mg). Fraction R5 (8.5 g) was chromatographed over MPLC using gradient elution of hexane (H) and ethyl acetate (EA); 25 to 80% of EA in 40 min, followed by 80 to 100% in 5 min to give seven subfractions. Purification using reversed phase Recycling HPLC by JAIGEL-ODS-AP-30, SP-120-15 column, H 2 O:MeOH (7:3, v/v) as a mobile phase at flow rate 10 mL/min giving 7 (34.3 mg), 8 (57.7 mg), 13 (60.8 mg) and 14 (34.7 mg).
The dichloromethane bark extract (12.0 g) was also fractionated using MPLC to afford sixteen fractions (B1-B16). Fractions B9 and B10 were refractioned using the same method as crude extract to give series of sub-fractions (B9a-R9m, B10a-F10p). Compound 10 (1.4 g) was obtained as a major from fractions B9-B11 using crystallization method. Fraction B9d (104.6 mg) was fractionated on Semi-Preparative HPLC Agilent 1200 over Sunfire C18 column (5 μm, 10 x 250 mm i. 
Cell culture and cytotoxicity assay (MTT):
The isolated compounds were evaluated for cytotoxicity using the established MTT method [10, 11] . All experiments were repeated in at least three independent experiments with 5-fluorouracil as positive control.
Supplementary data:
1 H-and 13 C-NMR of compound 3-9 are included in the separate file which will be published online.
